Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,170.00
Bid: 12,172.00
Ask: 12,174.00
Change: 108.00 (0.90%)
Spread: 2.00 (0.016%)
Open: 12,194.00
High: 12,266.00
Low: 12,054.00
Prev. Close: 12,062.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

REFILE-TREASURIES-U.S. yields little changed on caution about stimulus package

Tue, 26th Jan 2021 15:48

(Fixes typo in U.S. Treasury 10-year yield to 1.03% in 7th
paragraph)
By Gertrude Chavez-Dreyfuss
NEW YORK, Jan 26 (Reuters) - U.S. Treasury yields were
little changed to slightly higher in choppy trading on Tuesday,
after hitting three-week lows on the long end of the curve, as
investors remained cautious in the near term about the size of a
proposed U.S. stimulus package as well as the slow global
roll-out of coronavirus vaccines.
The U.S yield curve steepened modestly after flattening on
Monday. The spread between U.S. two-year and 10-year yields
widened modestly to 91.50 basis points.
U.S. Senate Majority Leader Chuck Schumer said late on
Monday that he and his fellow Democrats may try to pass much of
President Joe Biden's $1.9 trillion coronavirus relief bill
using a process that would bypass a Republican filibuster and
could allow it to pass with a majority vote.
"We think ultimately it's going to be smaller than the $1.9
trillion," said Mike Chang, interest rates strategist at Citi in
New York. "We have penciled in around $600 billion-$1 trillion.
Timing is another issue, not just the size - how long it will
take to get the whole thing through."
In addition, there have been coronavirus vaccine delivery
problems globally, especially in Europe.
AstraZeneca, which developed its vaccine with Oxford
University, told the European Union that it could not meet
agreed supply targets by the end of March. Pfizer Inc
said there would be a temporary impact on shipments of its
vaccine in late January to early February.
In mid-morning trading, the U.S. benchmark 10-year yield
fell to 1.03%, from 1.04% late on Monday. It earlier
fell to 1.026%, its lowest level since Jan. 6.
U.S. 30-year yields slid to 1.7955% from
Monday's 1.799%, after earlier dropping to a three-week low of
1.786%.
U.S. 20-year bond yields also weakened to a
three-week trough and were last down at 1.59%.
On the front end of the curve, U.S. two-year yields slipped
to 0.121% from 0.127% on Monday.
Also on Tuesday, the Treasury auctions a record $61 billion
in 5-year notes after a solid 2-year debt sale on Monday.
"We believe there will be demand as the Treasury market has
had a firm tone in recent sessions," Justin Lederer, rates
strategist at Cantor Fitzgerald, said in a research note.
"We, however, would not be surprised by a small back-up
leading into 1 pm (bid deadline) and/or small tail as market
participants are cautious at the current yield levels, as the
sector is trading at its richest levels since early January and
12 basis points lower than its high yield print a few weeks
ago," he added.
Ahead of the auction, U.S. five-year note yields were little
changed at 0.4119%.

January 26 Tuesday 10:28AM New York / 1528 GMT
Price Current Net
Yield % Change
(bps)
Three-month bills 0.08 0.0811 0.000
Six-month bills 0.085 0.0862 -0.003
Two-year note 100-1/256 0.123 -0.004
Three-year note 99-214/256 0.1805 0.000
Five-year note 99-210/256 0.4119 0.002
Seven-year note 99-80/256 0.727 0.002
10-year note 98-116/256 1.0414 0.001
20-year bond 96-12/256 1.6089 0.005
30-year bond 95-236/256 1.8024 0.003

DOLLAR SWAP SPREADS
Last (bps) Net
Change
(bps)
U.S. 2-year dollar swap 7.50 -0.25
spread
U.S. 3-year dollar swap 8.25 0.25
spread
U.S. 5-year dollar swap 10.00 0.50
spread
U.S. 10-year dollar swap 3.25 0.25
spread
U.S. 30-year dollar swap -24.00 0.00
spread


(Reporting by Gertrude Chavez-Dreyfuss
Editing by Paul Simao)

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.